AJMC - Change is Coming
|Articles|July 1, 1998

Supplements and Featured Publications

  • New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
  • Volume 4
  • Issue 7 Suppl

Participating Faculty

Download PDF: Participating Faculty

Articles in this issue

over 27 years ago

Introduction: Current Concepts in Hypertension Management and A Look Toward the Future

over 27 years ago

The Sixth Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure

over 27 years ago

Gene Polymorphism Influences Response to Angiotensin Blockade

over 27 years ago

New Drug Class Offers Benefits in Heart Failure

over 27 years ago

Comparative Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocking Agents on Left Ventricular Volumes in Elderly Patients with Heart Failure

over 27 years ago

Phase I Results of the Randomized Evaluation of Left Ventricular Dysfunction (RESOLVD) Trial

over 27 years ago

European Society of Cardiology: Angiotensin II Antagonists: Why is There So Much Excitement?

over 27 years ago

What are the Pharmacological Differences Between Angiotensin II Antagonists

over 27 years ago

Clinical Implications of Differences Between Angiotensin II Antagonists

over 27 years ago

Exploring the Benefits Beyond Blood Pressure Control

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text